CA1070315A - Procede pour la preparation de bis (heteroarylmethylthioethylguanidino) alcanes et produits obtenus - Google Patents

Procede pour la preparation de bis (heteroarylmethylthioethylguanidino) alcanes et produits obtenus

Info

Publication number
CA1070315A
CA1070315A CA283,619A CA283619A CA1070315A CA 1070315 A CA1070315 A CA 1070315A CA 283619 A CA283619 A CA 283619A CA 1070315 A CA1070315 A CA 1070315A
Authority
CA
Canada
Prior art keywords
compound
methyl
ethyl
formula
guanidino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA283,619A
Other languages
English (en)
Inventor
Graham J. Durant
Charon R. Ganellin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Application granted granted Critical
Publication of CA1070315A publication Critical patent/CA1070315A/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/26Radicals substituted by sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)
CA283,619A 1976-07-28 1977-07-27 Procede pour la preparation de bis (heteroarylmethylthioethylguanidino) alcanes et produits obtenus Expired CA1070315A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3139176 1976-07-28

Publications (1)

Publication Number Publication Date
CA1070315A true CA1070315A (fr) 1980-01-22

Family

ID=10322405

Family Applications (1)

Application Number Title Priority Date Filing Date
CA283,619A Expired CA1070315A (fr) 1976-07-28 1977-07-27 Procede pour la preparation de bis (heteroarylmethylthioethylguanidino) alcanes et produits obtenus

Country Status (15)

Country Link
JP (1) JPS5315370A (fr)
AU (1) AU2734677A (fr)
BE (1) BE857218A (fr)
CA (1) CA1070315A (fr)
DE (1) DE2733953A1 (fr)
DK (1) DK331877A (fr)
ES (1) ES461100A2 (fr)
FI (1) FI772293A (fr)
FR (1) FR2359840A1 (fr)
IL (1) IL52544A0 (fr)
LU (1) LU77845A1 (fr)
NL (1) NL7708375A (fr)
NO (1) NO772668L (fr)
PL (1) PL107847B1 (fr)
ZA (1) ZA774552B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4309435A (en) 1978-10-16 1982-01-05 Imperial Chemical Industries Ltd. Antisecretory guanidine derivatives and pharmaceutical compositions containing them
FR2446829A1 (fr) * 1978-11-16 1980-08-14 Glaxo Group Ltd Derives de polymethylene disubstitues en alpha, omega, procede pour leur preparation et compositions pharmaceutiques les contenant
JPS57102852A (en) * 1980-12-19 1982-06-26 Shionogi & Co Ltd Dicarboxylic acid diamide
EP4196793A1 (fr) 2020-08-11 2023-06-21 Université de Strasbourg Bloqueurs de h2 ciblant des macrophages du foie pour la prévention et le traitement d'une maladie du foie et du cancer

Also Published As

Publication number Publication date
DE2733953A1 (de) 1978-02-02
FR2359840A1 (fr) 1978-02-24
ZA774552B (en) 1978-06-28
DK331877A (da) 1978-01-29
BE857218A (fr) 1978-01-27
IL52544A0 (en) 1977-10-31
AU2734677A (en) 1979-02-01
NL7708375A (nl) 1978-01-31
PL107847B1 (pl) 1980-03-31
FI772293A (fr) 1978-01-29
LU77845A1 (fr) 1977-10-25
JPS5315370A (en) 1978-02-13
PL199908A1 (pl) 1978-11-20
ES461100A2 (es) 1978-12-01
NO772668L (no) 1978-01-31

Similar Documents

Publication Publication Date Title
US3876647A (en) Certain n-cyanoguanidines
US3881015A (en) Pharmaceutical compositions and methods of inhibiting histamine activity with isothiourea compounds
US4145546A (en) 4-Pyrimidone compounds
IE44124B1 (en) Cyclobutene-diones
US3905984A (en) Pyridyl substituted thioalkyl-and oxyalkyl-thioureas and ureas
CA1062263A (fr) Composes antagoniste de l'histamine (recepteur h-2)
US4426526A (en) Alkoxypyridyl alkylamines
US3920822A (en) Inhibition of histamine activity with cyanoguanidines
USRE29761E (en) Guanidino, thioureido and isothioureido derivatives containing imidazole groups
US4265896A (en) Amidinosulphonic acid derivatives
CA1070315A (fr) Procede pour la preparation de bis (heteroarylmethylthioethylguanidino) alcanes et produits obtenus
US4013659A (en) Certain n,n'-disubstituted guanidine compounds and their use
CA1075700A (fr) Preparation de derives des acides amidinoformiques
US4374839A (en) Pharmacologically active 1,3-bis[(2-heterocyclyl-methyl-thio)ethyl)ethyl)guanidino]alkane derivatives
US4036971A (en) Amidino compounds
US4118496A (en) Heterocyclic-methylthioalkyl-amidines
US3971786A (en) Pyridyl alkylguanidine compounds, composition therewith, and methods of inhibiting H-2 histamine receptors
US4652572A (en) 2-(furanyl alkylamino or thienyl alkylamino or phenylalkylamino)-3-carboxy (or hydroxy)-pyridines
US4060621A (en) Pyridyl alkylguanidine compounds
US4219553A (en) Alkoxy pyridyl substituted alkanes
US4210652A (en) Pharmacologically active 1,3-bis[1-(2-heteroalkylthio)ethylamino)-2-nitrovinyl-1-amino]propane derivatives
US4133886A (en) Guanidino, thioureido, isothioureido and nitrovinylamino derivatives of pyridine
GB1565205A (en) Heterocyclic sulphoxides
Bolhofer et al. Inhibitors of gastric acid secretion: antisecretory 2-pyridylurea derivatives
DE2733952A1 (de) Alpha, omega-diaminoalkylenverbindungen

Legal Events

Date Code Title Description
MKEX Expiry